NCT06859489

Brief Summary

AGAPE aims to implement an advanced technology platform that provides services to older adults, formal and informal caregivers, and caregiving organizations.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 6, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 13, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 28, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 5, 2025

Completed
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

March 13, 2025

Status Verified

February 1, 2025

Enrollment Period

9 months

First QC Date

February 28, 2025

Last Update Submit

March 11, 2025

Conditions

Keywords

active and healthy ageingdigital health literacyolder adults

Outcome Measures

Primary Outcomes (18)

  • System Usability Scale (SUS)

    Innovation adoption profile transition of the older adult, innovation adoption profile transition of the caregiver, evaluation of usability and technostress levels of the older adult and their respective caregivers in relation to the AGAPE platform, assessed using the SUS scale and the Technostress questionnaire throughout the different phases of the study. Answer: 1 (strongly disagree) - 5 (strongly agree). Minimum= 10 ; Maximum= 50.

    From the enrollment to the end of treatment at 12 months (T2)

  • System Usability Scale (SUS)

    Innovation adoption profile transition of the older adult, innovation adoption profile transition of the caregiver, evaluation of usability and technostress levels of the older adult and their respective caregivers in relation to the AGAPE platform, assessed using the SUS scale and the Technostress questionnaire throughout the different phases of the study. Answer: 1 (strongly disagree) - 5 (strongly agree). Minimum= 10 ; Maximum= 50.

    From the enrollment to 6 months (T1)

  • System Usability Scale (SUS)

    Innovation adoption profile transition of the older adult, innovation adoption profile transition of the caregiver, evaluation of usability and technostress levels of the older adult and their respective caregivers in relation to the AGAPE platform, assessed using the SUS scale and the Technostress questionnaire throughout the different phases of the study. Answer: 1 (strongly disagree) - 5 (strongly agree). Minimum= 10 ; Maximum= 50.

    From the enrollment to 1 month (T0)

  • Ad Hoc socio-demographic questionnaire

    the aim of the questionnaire is recording the socio-demographic charateristics of the sample

    From the enrollment to 6 months (T1)

  • Ad Hoc socio-demographic questionnaire

    the aim of the questionnaire is recording the socio-demographic charateristics of the sample

    From the enrollment to 12 months (T2)

  • Ad Hoc socio-demographic questionnaire

    the aim of the questionnaire is recording the socio-demographic charateristics of the sample

    From the enrollment to 1 month (T0)

  • TechnoStress Questionnaire

    it's a psychological questionnaire designed to measure the level of stress related to the use of technology.

    From the enrollment to 12 months (T2)

  • TechnoStress Questionnaire

    it's a psychological questionnaire designed to measure the level of stress related to the use of technology

    From the enrollment to1 month (T0)

  • TechnoStress Questionnaire

    it's a psychological questionnaire designed to measure the level of stress related to the use of technology

    From the enrollment to 6 months (T1)

  • Questionnaire for Innovation Adoption

    it explores how and why individuals decide to embrace or reject innovation such as technology

    From the enrollment to1 month (T0)

  • Questionnaire for Innovation Adoption

    it explores how and why individuals decide to embrace or reject innovation such as technology

    From the enrollment to 6 months (T1)

  • Questionnaire for Innovation Adoption

    it explores how and why individuals decide to embrace or reject innovation such as technology

    From the enrollment to 12 months (T2)

  • EQ-5D-5L

    this questionnaire explores the quality of life for european samples. Answer: 1 (no problems) to 5 (extreme problems).

    From the enrollment to1 month (T0)

  • EQ-5D-5L

    this questionnaire explores the quality of life for european samples. Answer: 1 (no problems) to 5 (extreme problems).

    From the enrollment to 12 months (T2)

  • EQ-5D-5L

    this questionnaire explores the quality of life for european samples. Answer: 1 (no problems) to 5 (extreme problems).

    From the enrollment to 6 months (T1)

  • UCLA Loneliness Scale

    this scale is used for investigate the loneliness of the sample. Answer: 0 (Never) to 3 (Often).

    From the enrollment to 6 months (T1)

  • UCLA Loneliness Scale

    this scale is used for investigate the loneliness of the sample. Answer: 0 (Never) to 3 (Often).

    From the enrollment to1 month (T0)

  • UCLA Loneliness Scale

    this scale is used for investigate the loneliness of the sample. Answer: 0 (Never) to 3 (Often).

    From the enrollment to 12 months (T2)

Study Arms (4)

primary end-users

EXPERIMENTAL

The Agape platform will offer a series of customized and integrated services to meet the needs of end users, including: 1. promotion of a healthy and active lifestyle; 2. socialization services; 3. digital health literacy service.

Device: Active aGeing And Personalised service's Ecosystem (AGAPE)

formal caregiver

OTHER

formal caregivers are social operators with different background. The service provides support to formal caregivers in defining and updating the patient's activity plan over time, ensuring it adapts to their needs.

Device: Active aGeing And Personalised service's Ecosystem (AGAPE)

informal caregiver

OTHER

Informal caregivers will be able to receive notifications of any anomalies on their devices and, if necessary, draw the attention of the formal caregiver.

Device: Active aGeing And Personalised service's Ecosystem (AGAPE)

Tertiary end users

OTHER

Tertiary end users (i.e., care organizations, local authorities, municipalities). The Agape platform will offer a series of customized and integrated services to meet the needs of end users, including: 1. promotion of a healthy and active lifestyle; 2. socialization services; 3. digital health literacy service.

Device: Active aGeing And Personalised service's Ecosystem (AGAPE)

Interventions

The experimental protocol is structured into two phases: Phase 1 (pre-pilot) - Preliminary assessment of the functionality and usability of the AGAPE platform by older adults and caregivers, divided into: Living lab: Three sessions to progressively explore and test the platform and its services, including workshop activities. Testing phase: Use of the platform in the home environment of older adults for one month. Phase 2 (pilot study) - Evaluation of the platform's impact on the daily lives of older adults, caregivers, and care organizations, with a 12-month involvement for each user.

Tertiary end usersformal caregiverinformal caregiverprimary end-users

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age ≥ 65 years
  • Ability to understand the rationale and characteristics of the study and to provide informed consent
  • Low level of frailty, indicated by a score \<5 on the Rockwood Clinical Frailty Scale (Rockwood et al., 2005)
  • Absence of moderate to severe cognitive impairment, indicated by a Mini-Mental State Examination (MMSE) score ≥ 24 (adjusted score; Folstein, 1975)
  • Absence of severe comorbidities and clinically relevant diseases

You may not qualify if:

  • Age below 65 years
  • Inability to provide informed consent for participation in the study
  • High level of frailty (Rockwood Clinical Frailty Scale \> 5)
  • Presence of cognitive impairment (adjusted MMSE score \< 24)
  • Diagnosed anxiety and depression
  • Presence of severe disability and serious health conditions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Fondazione Don Carlo Gnocchi, Firenze

Florence, Italy

Location

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Four categories of end users will be involved: 1. Primary end users (i.e., older adults); 2. Secondary end users, in the figure of informal caregivers (i.e., relatives and friends of the elderly); 3. Secondary end users, in the figure of formal caregivers (i.e., social and health workers with different professional trainings, such as nurses, home care workers, geriatricians etc...); 4. Tertiary end users (i.e., care organizations, local authorities, municipalities). The Agape platform will offer a series of customized and integrated services to meet the needs of end users, including: 1. promotion of a healthy and active lifestyle; 2. socialization services; 3. digital health literacy service.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 28, 2025

First Posted

March 5, 2025

Study Start

February 6, 2024

Primary Completion

November 13, 2024

Study Completion

March 31, 2025

Last Updated

March 13, 2025

Record last verified: 2025-02

Locations